Ultrasonic contrast studies for the detection of cardiac shunts  by Valdes-cruz, Lilliam M. & Sahn, David J.
978 lACC Vol. 3. No.4
April 1984:978-85
SEMINAR ON CONTRAST TWO-DIMENSIONAL ECHOCARDIOGRAPHY:
APPLICATIONS AND NEW DEVELOPMENTS. PART II*
Eliot Corday, MD, FACC, Pravin M. Shah, MD, FACC and Samuel Meerbaum, PhD, FACC,
Guest Editors
Ultrasonic Contrast Studies for the Detection of Cardiac Shunts
LlLLlAM M, VALDES-CRUZ, MD, FACC, DAVID J. SAHN, MD, FACC
La Jolla, California
Contrast echocardiography has achieved importance in
the diagnosis of cardiac shunt lesions. The technique
provides information about flow patterns and serves as
an adjunct to identifying communications that may be
too small to image, even with high resolution real time
scanning. This report reviews clinical applications and
experiences in the use of standard, peripherally injected
echocardiographic contrast agents for the detection of
atrial septal defect, ventricular septal defect and patent
ductus arteriosus. The importance and development of
transpulmonary contrast agents capable of crossing the
pulmonary capillary bed to opacify the left ventricle are
reviewed and experience with a variety of experimental
Contrast echocardiography has gained wide acceptance as
an extremely sensitive technique for verifying the presence
of intracardiac and extracardiac shunts. Most commonly, it
has been used in the outpatient setting to detect an intra-
cardiac right to left shunt from peripheral venous contrast
injection; however, it has also gained wide acceptance in
the cardiac catheterization laboratory and the neonatal in-
tensive care unit as an aid in the detection of intracardiac
left to right shunts and left to right shunting patent ductus
arteriosus. The last few years have seen a flurry of interest
in developing a contrast agent that would opacify the left
side of the heart after injection into a peripheral vein or
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echocardiographic contrast agents is presented.
Agents opacifying the left ventricle after intravenous
injection are capable of providing direct ultrasonic con·
trast imaging of congenital left to right shunts. Further,
recent experience with an experimental standardized,
gas-producing contrast agent in an open chest animal
model with an experimentally produced ventricular sep-
tal defect suggests that a combination of an experimental
right heart agent that produces a measurable arid re-
producible amount of contrast effect, with a videoden-
sitometric system capable of quantifying both positive
and negative contrast effects, may provide an ultrasonic
method for evaluating the magnitude of cardiac shunts.
right-sided cardiac structure. These techniques, however,
are still in the experimental stage and have not been used
regularly in the clinical setting.
In this report, we review the use of contrast echocardi-
ography for detection of right to left and left to right intra-
and extracardiac shunts. We also present our experimental
data on the use of contrast agents that cross the pulmonary
capillary bed and of a standardizable, quantifiable gas-pro-
ducing experimental right heart contrast agent.
Review of Clinical Experience
Atrial Shunts
In 1968, Levin et a1. (l) demonstrated angiographically
that patients with an uncomplicated secundum atrial septal
defect had a right to left atrial shunt occurring during the
rapid filling phase of ventricular diastole and at the onset
of ventricular contraction for a period of about 80 to 100
ms. Although the clinical and echocardiographic diagnosis
of an atrial septal defect is usually relatively easy to make
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in patients with a large uncomplicated defect, in those with
a smaller atrial defect or in adults whose atrial septum is
difficult to visualize, the echocardiographic diagnosis is often
made with the aid of a peripheral venous injection of an
echocardiographic contrast agent that is seen to cross the
atrial septum and opacify the left atrium.
Techniques and contrast agents. Various techniques
and contrast materials are used in different echocardio-
graphic laboratories. Most commonly, for peripheral venous
injections, either 5% dextrose in water, normal saline so-
lution or indocyanine green dye followed by a normal saline
flush, have been used with variable degrees of success. In
our laboratory, we used either 5% dextrose in water or
normal saline solution in the outpatient setting. In infants
and postoperative patients, we commonly used the patient's
own blood, withdrawn and rapidly reinjected, to avoid fluid
overloading, which is so critical in the pediatric age group
(2).
In the presence of an atrial septal defect, even with slight
degrees of right to left shunt, the contrast echocardiographic
microbubbles can be seen in the left side of the heart within
a few cardiac cycles after the injection of contrast medium
(Fig. 1). Our work and that of other investigators (2-5) has
confirmed that contrast echocardiography can detect shunts
as small as 3 to 5%, and that it is more sensitive than
indicator-dilution techniques or oximetry. Because with
conventional echocardiographic contrast agents the sus-
pended microbubbles are filtered by the lungs and do not
normally appear in the left side of the heart after right-sided
injection, it has been postulated that the appearance of even
one microbubble in the left atrium is confirmatory of the
presence of an atrial defect (6). Given the proven sensitivity
of contrast echocardiography, we agree with this postulate;
however, larger clinical series (3) have demonstrated some
false negative studies, suggesting technical difficulties in
either the contrast technique or the ability to visualize the
intracardiac structures.
Positive and negative contrast jets. Problems with de-
tection of a small right to left shunt in the presence of a
predominantly left to right shunting atrial lesion prompted
a study (7) to examine the positive and negative contrast
jets seen on two-dimensional echocardiograms after venous
injection. With an intact interatrial septum, the mass of
contrast echoes homogeneously opacities the right atrium
and outlines the right atrial border of the septum, even in
patients in whom echocardiograpbic dropout may simulate
a defect. With left to right shunting, contrast medium fills
the right atrium; however, the noncontrasted, nonopacitied
left atrial blood passing through the defect may sometimes
be visualized because it superimposes a negative or contrast-
free area that outlines the septal defect (7). Weyman et al.
(7) observed that the timing of the negative contrast effect
occurs during end-systole and early diastole and is consistent
Figure 1. Patient with a secundum atrial septal defect. Top, Two-
dimensional echocardiogram (subcostal view) before contrast me-
dium injection. Bottom, After peripheral venous injection of nor-
mal saline solution, the right atrium (RA) is completely opacified.
Contrast medium is seen to enter the left atrium (LA) through the
atrial septal defect, thereby confirming its presence. (Reproduced
with permission from Sahn DJ and Martinus Nijhoff Publishers
[6].)
with the findings of Levin et al. (1) on the timing of left to
right shunting in an atrial defect. Nonetheless, a major prob-
lem in detecting negative contrast jets is that they are usually
small and can be masked by the very bright reflections from
the positive contrast around them.
Ventricular Shunts
Hemodynamics. A ventricular septal defect can occur
as an isolated lesion or as part of a complex cardiac defect.
Right to left shunting may occur through a ventricular septal
defect when the peak right ventricular systolic pressure reaches
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or exceeds 70 mm Hg. In patients with this degree of in-
creased right ventricular pressure, a right to left pressure
gradient may be established at the onset of isovolumic re-
laxation when the left ventricular pressure decreases more
rapidly than that in the right ventricle. In patients with equal
systolic ventricular pressures, right ventricular pressure is
higher than left ventricular pressure during late ventricular
ejection and isovolumic relaxation. Right to left shunting
occurs at these times in the cardiac cycle, either from the
right ventricle to the left or from the right ventricle directly
to the aorta (8). Such hemodynamics occur in many infants
with a large defect. In these infants, peripheral echocardio-
graphic contrast injection serves to confirm the presence of
the ventricular septal defect and can serve as a useful adjunct
to the real time two-dimensional echocardiographic
examination.
Left-sided contrast studies. Usually, isolated small to
moderate ventricular septal defects do not have a right to
left component to the shunt. As in atrial defects, appearance
of a negative contrast echocardiographic jet, superimposed
on the contrast-filled right ventricle, can aid in the confir-
mation of a ventricular septal defect. However, in most
cases, a left ventricular contrast echocardiogram is needed
for absolute confirmation of the site of shunting. At present,
this has to be performed during the course of cardiac cath-
eterization because it requires a catheter to be positioned in
the left side of the heart, either in the left atrium or in the
left ventricle. These left-sided contrast studies can be com-
plementary to angiography for demonstration of multiple
ventricular septal defects or a ventricular septal defect cov-
ered on the right side by the septal leaflet of the tricuspid
valve (9).
Right-sided contrast studies. Nonetheless, standard right-
sided echocardiographic contrast injections can still aid in
the evaluation of right ventricular hemodynamics in the
presence of a ventricular defect. On the basis of previous
work done by Levin et al. (1), Serwer et al. (10) were able
to demonstrate five distinct patterns of M-mode echocar-
diographic contrast in patients with ventricular septal defect.
I) Those with a right to left ventricular pressure ratio less
than 60% did not show any evidence of contrast medium
in the left ventricle after venous injection. 2) In patients
whose ventricular pressure was 60 to 80% of systemic, and
the pulmonary to systemic flow ratio was between 2: I and
5: I, transient flow of echocardiographic contrast medium
was seen to occur from the right to left ventricle beginning
during the period of early ventricular filling. In mid to late
diastole, contrast medium was washed back into the right
ventricle. 3) In patients with right ventricular pressure equal
to systemic, and pulmonary to systemic flow ratio greater
Figure 2. Infant with a patent ductus arter-
iosus (PDA): short-axis view at the level of
the great vessels. Contrast medium is seen
filling the descending aorta (Ao) and entering
the main pulmonary artery (PA) (arrow)
through the open ductus after injection through
the umbilic~l artery line. This study confirms
the presence of the left to right shunting pat-
ent ductus arteriosus in the infant.
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than 3: 1, echocardiographic contrast medium was seen to
cross from right to left early in ventricular filling and remain
in the left ventricle and aorta throughout the cardiac cycle.
In these patients, the major shunt was left to right; no patient
had evidence of increased pulmonary vascular resistance or
significant pulmonary valve stenosis. 4) In patients with
clinically significant pulmonary stenosis and right to left
shunt with pulmonary to systemic flow ratio varying from
0.4: 1 to 0.8: 1, echocardiographic contrast medium was seen
to appear early in the left ventricle and remain in the left
ventricle and aorta throughout the cardiac cycle. In this
group of patients, the appearance time of the echocardio-
graphic contrast medium occurred earlier than in pattern 3.
5) In patients with increased pulmonary vascular resistance
greater than 15 units/m2 , the right to left contrast jet ap-
peared in the left ventricle extremely early and was seen to
remain there throughout the cardiac cycle.
Thus, right-sided echocardiographic injections can aid in
the evaluation and follow-up of patients with a ventricular
septal defect. Injections in the left side of the heart, although
invasive, can still serve as an adjunct to conventional an-
giocardiography in the delineation of a complex defect.
Extracardiac Shunts
Patent ductus arteriosus. The most common extracar-
diac shunt posing a diagnostic dilemma is the patent ductus
arteriosus, which can be "silent" in premature infants with
a complicated perinatal course (11). Within this context,
M-mode echocardiography from the suprasternal notch,
coupled with contrast injections through an umbilical artery
catheter, have been quite useful for demonstrating the pres-
ence of a left to right shunting ductus, and are used in many
nurseries as a fairly noninvasive standard for the presence
of a left to right ductal shunt (12,13). The suprasternal notch
view affords a simultaneous view of the aortic arch and the
pulmonary artery, usually its right branch (14). As such, in
babies with a patent ductus arteriosus, injection of contrast
medium in the thoracic descending aorta through an um-
bilical artery catheter opacifies not only the aorta but also
the branch pulmonary arteries (13). This technique and the
peripheral venous injection route, when coupled with two-
dimensional echocardiography, allow a dramatic echocar-
diographic demonstration of the presence and direction of
ductal shunting, not only from the suprasternal notch as
explained previously, but also from the parasternal short-
axis view, which can usually demonstrate contrast material
passing in either direction through the imaged patent ductus
arterious (Fig. 2) (15).
Transpulmonary Passage of Echocardiographic
Contrast Material
The production of left-sided contrast from peripheral ve-
nous or right-sided cardiac injections has been the subject
of much interest in the recent reports on contrast echocar-
diography. Early efforts to achieve left-sided contrast by trans-
pulmonary passage of right-sided contrast agents involved
injection of conventional echocardiographic contrast agents
from a pulmonary wedge position; however, this restricted
the use of the technique to the cardiac catheterization lab-
oratory or intensive care unit, and other than avoiding left-
sided cardiac entry, did not offer significant advantages over
Figure 3. Open chest dog: three sequential images after the in-
jection of 75% dimethylsulfoxide (DMSO). Top, Control image
of the four chamber view. Middle, After contrast medium injec-
tion, the right ventricle (RV) has opacified; the left ventricle (LV)
remains free of contrast effect. Bottom, The right ventricle begins
to clear. Contrast effect having transversed the pulmonary vascular
bed is appearing in the left atrium (LA) and left ventricle.
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direct left-sided echocardiographic contrast injection. More
recently, experimental echocardiographic contrast agents have
been tested that could appear on the left side of the heart
after peripheral venous injection. These could obviously
provide an important method for detecting left to right shunts.
Pulmonary wedge injection. In 1979, Bommer et al.
(16) reported studies in which injection of contrast agents
through catheters positioned in the pulmonary wedge in dogs
produced echocardiographic contrast that appeared on the
left side of the heart. Subsequently in 1979 and 1980, Reale
et al. (17) in Italy reported their clinical experience in 68
patients who underwent pulmonary wedge injections during
the course of diagnostic cardiac catheterization. Initially,
these investigators used carbon dioxide, but later had equal
success with conventional contrast agents, such as saline
solution or indocyanine green, as long as the injections were
made in the pulmonary wedge position. They achieved an
extremely high success rate for pulmonary passage of echo-
cardiographic contrast medium with subsequent demonstra-
tion of left to right shunting if such a defect was present.
In their experience and that of Meltzer et al. (18), no clinical
complications were observed after these contrast studies.
Unfortunately, wedge injection can hardly be considered
within the realm of semi-invasive procedures.
Peripheral venous injection. In 1979, Bommer et al.
(16) reported the use of microbubbles, 2 to 10 J.L diameter,
that appeared to cross the pulmonary capillary bed and opa-
cify the left side of the heart after venous injection in ex-
perimental animals. Meltzer et al. (19) produced left-sided
contrast in pigs after right-sided cardiac injections of diethyl
ether and hydrogen peroxide. We recently conducted two
studies in our laboratory designed to investigate transpul-
monary passage of contrast agents injected into a peripheral
vein and to evaluate the dynamics of positive and negative




Transpulmonary contrast medium. Our first series of
experiments were conducted on 20 open chest anesthetized
mongrel dogs. Injections of 11 contrast agents currently used
intravenously in human beings for various clinical indica-
tions were made into the dogs' external jugular vein. Cardiac
imaging was performed by directly positioning the echo
transducer over the cardiac apex to examine the heart in a
four chamber plane after a median sternotomy. The echo-
cardiographic equipment used was a digital 5 MHz me-
chanical sector scanner (SKI 5000) with a standardized and
automated gain control system.
Agents were selected for their surfactant properties, their
capability to dissolve gases or their particulate nature. In
all cases, it was postulated that either microbubbles or mi-
croparticles might cross the pulmonary capillaries and opa-
cify the left side of the heart.













Figure 4. Ratio of left (LV) to right (RV) ventric-
ular density x 10 (that is, I == LV:RV density
ratio of 0.1,5 == LV:RV ratio of 0.5) (ordinate) 10
is shown for the contrast agents studied in open
chest dogs. LV:RV density ratio was calculated early
in the injection sequence, immediately after right
ventricular filling and late during the injection se-
quence after the left ventricle had opacified sub-
stantially and the right ventricle was washing out.
Mean ± standard error of the estimate for the den-
sity ratio is shown for 25 injections of each agent
in the 20 dogs studied. Agents shown on the ab-
scissa include ALB + CO2 == salt-poor albumin
gasified with carbon dioxide; DMSO == 75% di-
methylsulfoxide; FLU + CO2 = fluorocarbon-oxy-
pherol gasified with carbon dioxide; FLU + O2 ==
fluorocarbon-oxypherol gasified with oxygen; H20 2
= 0.3% hydrogen peroxide; IND+C02 = indo-
cyanine green with carbon dioxide; LIP == 10%
Liposyn; NS + CO2 == cold normal saline solution
gasified with carbon dioxide; PAR == paraldehyde;
PROPGYL == propylene glycol; SAT SUGAR =
saturated suspension of biologically active polysac-
charides. See text for details.
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Figure 5. Two month old infant: two sequential echocardio-
graphic frames from the superior vena caval injection of Liposyn.
Upper panel, Control four chamber view, Lower panel. Dense
opacification of the right ventricle (RY) is seen. After transpul-
monary passage of the contrast agent, opacification of the left
atrium (LA) and left ventricle is seen. Contrast medium did not
appear in the left atrium until four beats after right ventricular
filling. The lack of early right ventricular washout in our experience
with human subjects compared with findings in our experimental
animal study was probably related to slower injection of contrast
medium through a smaller in-dwelling line.
travenously as a surfactant hypnotic agent; 2) 8% propylene
glYCOl, a surfactant used intravenously in low doses as a
suspending agent for drugs; 3) indocyanine green gasified
with carbon dioxide; 4) salt-poor albumin gasified with car-
bon dioxide; 5) OxypheroI20%, a synthetic oxygen carrying
fluorocarbon, gasified with oxygen; 6) OxypheroI20%, gas-
ified with carbon dioxide; 7) 0.3% hydrogen peroxide, re-
portedly used in human subjects in China as a contrast agent
(21); 8) a supersaturated solution of saccharides; 9) 75%
dimethylsulfoxide (DMSO) used intravenously in Europe,
Japan and the United States for arthritis and for reducing
cerebral edema; 10) 10% Liposyn, a fat emulsion used for
intravenous alimentatin in debilitated humans; and II) 2°C
normal saline solution gasified with carbon dioxide.
After forceful injection of 5 ml agitated aliquots of these
solutions in a random coded sequence, the echocardio-
graphic contrast medium densities in the right and left side
of the heart were measured simultaneously using an analog
video waveform analyzer. The relative intensity of contrast
in each ventricle was assessed by calculating the ratio of
left to right ventricular video intensity early and late during
the injection sequence.
Quantitation of ventricular septal defect shunting. In
our second study, we performed contrast echocardiography
on four open chest dogs in which a ventricular septal defect
measuring 8 to 12 mm in diameter was produced surgically
by advancing a tissue borer through a purse string right
atrial incision across the tricuspid valve and through the
septum. In these studies, we performed duplicate external
jugular venous injections of 3.5 cc of a solution of I g of
SHU 454C (Berliscan Inc.). This is an experimental gas-
producing echocardiographic contrast agent designed to cre-
ate a reproducible right ventricular contrast effect and then
dissipate in the lungs. Aortic and pulmonary flows were
measured with electromagnetic flow meters positioned around
each vessel, and pressures in the right and left ventricles or
aorta were constantly monitored during the study. Ventric-
ular pressures and pulmonary and systemic flow ratios were
altered by selective banding of the aorta or pulmonary artery.
Thirty-five different shunt sizes were evaluated with a range
of pulmonary to systemic flow ratios of I. I: I to 7: I. Video
intensities in the right and left ventricles and in the areas
of negative nad positive jets related to the ventricular septal
defect were measured with a Microsonics videodensitometer.
Results
Transpulmonary contrast. In this study, we observed
that all substances we selected completely opacified the right
ventricle, and all were seen to cross the pulmonary capillary
bed rapidly to appear in the left heart in measurable quan-
tities (Fig. 3). The highest videodensities in the left heart
chambers were achieved by saturated sugar, 75% dimeth-
ylsulfoxide, 10% Liposyn or cold gasified saline solution.
Further, the contrast density produced by these four sub-
stances washed out promptly from the right heart, so that
the ratio of left to right ventricular video density increased
with time (Fig. 4). These results suggested that in the pres-
ence of an intracardiac left to right shunt, reopacification
of the right heart could be detected with these four substances.
Experimental ventricular septal defect. When we per-
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formed venous injections of these four substances in the
dogs with a surgically created ventricular septal defect, we
demonstrated the appearance of microbubbles in the left
ventricle through the mitral valve. A small amount of this
left ventricular contrast medium was seen to pass through
the ventricular septal defect into the right ventricle.
Clinical trials. Finally, under an approved human sub-
jects research protocol with patients providing informed
consent, we conducted preliminary trials in five human sub-
jects with normal cardiac anatomy who were receiving 10%
Liposyn for clinically indicated reasons (malnutrition, de-
bilitation and malignancy). Figure 5 is an example of a 10%
Liposyn injection in an infant with no intracardiac shunt.
The infant was receiving intravenous hyperalimentation for
malnutrition and received I cc of Liposyn, that is, % of his
hourly dose as a bolus. This figure demonstrates opacifi-
cation of the left ventricle through the open mitral valve
after transpulmonary passage of 10% Liposyn.
Quantitation of ventricular septal defect shunting. In
our study of quantitative contrast echocardiography in the
animals with a ventricular septal defect, SHU 454C yielded
reproducible right ventricular contrast intensity and filling
as measured with the videodensitometer. All video densities
for the 70 injections were between 220 and 250 video units
in the right ventricle.
Positive contrast areas moving from the right into the left
ventricle, indicative of a right to left shunt, were present
when right ventricular systolic peak pressure was greater
than 35% of systemic pressure. These occurred mostly in
diastole and were also seen after premature ventricular con-
tractions. Negative contrast effects within the right ventri-
cle, indicative of a left to right ventricular shunt, were
quantified by measuring the negative contrast area and mul-
tiplying it by the difference between the video intensity of
the negative jet area compared with the surrounding opa-
cified right ventricle. The size of these quantitated negative
jets (as an area times a change in density) correlated roughly
with the pulmonary to systemic flow ratios for the 35 shunts
evaluated (r = 0.82, probability [p] < 0.1). Bidirectional
shunting was also observed in our model (Fig. 6). Unfor-
Figure 6. Dog with surgically created ventricular septal defect
(VSD). Four chamber view showing contrast opacification of the
right ventricle (RV) by a standardized experimental contrast agent
after venous injection. Negative (neg) contrast effect is denoted
(+ ) at the right ventricular side of the ventricular septal defect,
while positive (pos) contrast opacification is visualized traversing
the septum from the right to the left ventricle (LV) at the same
instant. The alphanumerics at the bottom of the figure contain
instructions and measurements from the computerized
videodensitometer.
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t~nately, none of the transpulmonary contrast agents we
tested produced enough recirculated left to right shunted
contrast medium through the ventricular septal defect at a
time when the right ventricle had cleared of contrast for us
to test direct positive left to right contrast quantitation of
ventricular septal defect shunting.
Discussion
Although preliminary, these studies suggest that stand-
ardized two-dimensional echocardiographic contrast agents,
coupled with videodensitometry, may have quantitative ap-
plications for evaluations of shunts, even if they do not
cross the lungs. A variety of additional and important po-
tential applications exist for acceptable left heart echocar-
diographic contrast agents, including digital video subtrac-
tion echocardiographic quantitation, quantitative shunt
detection and myocardial perfusion studies. Further work
aimed at selecting safe and reproducible right or left-sided
contrast agents will provide new capabilities for
echocardiography.
Implications. At present, clinically available echocar-
diographic contrast techniques offer reliable, reproducible
and rninimally invasive methods to detect and confirm the
presence of atrial, ventricular and extracardiac shunts in
children and adults with simple or complex defects. Pre-
viously, contrast echocardiography had not been quantita-
tive; however, recent development of standardized contrast
agents suggests shunt quantitation may be possible in the
future. Although substantial clinical applications already
exist for contrast echocardiography in children and adults
with shunt lesions, new experimental contrast agents hold
forth the promise of improved shunt detection and quantitation.
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